Skip to main content
Signal8

DOCKERY CARL

SEC insider (Form 3/4/5 filer). CIK 0001618149. Director at AYTU BIOPHARMA, INC (AYTU). 5 reported Form 4/5 transactions since Sep 2024; latest on Jul 28, 2026. Located in DENVER, CO.

Companies DOCKERY CARL has filed insider reports for

  • AYTU BIOPHARMA, INC (AYTU): Director
DOCKERY CARL profile photo

DOCKERY CARL

CIK: 0001618149

Transaction Breakdown

Open Market Buys (P)1 (20.0%)

High conviction signal

Open Market Sales (S)1 (20.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AYTU BIOPHARMA, INC logo
AYTU

AYTU BIOPHARMA, INC

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • AYTU BIOPHARMA, INC logo
    AYTU

    AYTU BIOPHARMA, INC

    Jul 28, 2026
    Award
    Direct
    10K shares-
  • AYTU BIOPHARMA, INC logo
    AYTU

    AYTU BIOPHARMA, INC

    Oct 3, 2025
    Award
    Direct
    10K shares-
  • AYTU BIOPHARMA, INC logo
    AYTU

    AYTU BIOPHARMA, INC

    Nov 6, 2024
    Award
    Direct
    1.5K shares-
  • AYTU BIOPHARMA, INC logo
    AYTU

    AYTU BIOPHARMA, INC

    Dec 30, 2020
    Sale
    Indirect
    209 shares at avg. $6.01$1K
  • AYTU BIOPHARMA, INC logo
    AYTU

    AYTU BIOPHARMA, INC

    Nov 18, 2020
    Purchase
    Indirect
    10K shares at avg. $0.92$9K

1-5 of 5